News 2018-10-06
Porton will attend 2018 CPhI WW
We own and operate 4 Process Technology Centers and 2 Manufacturing Sites [including one US FDA, Japan PDMA-approved facilities] across China. Supported by >1,500 customer first-oriented employees [including >500 Process Scientists, Operations, Quality Assurance, EHS and Program Management professionals]. Our sites are operated to global quality and environmental standards under a centralized management system.

Others
More
News 2026-07-08
Porton Advanced’s UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
Porton Advanced’s UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance

News 2026-07-03
Porton Delivers Dual-Payload ADC IND, Advancing Next-generation Conjugate Drug Development
Porton One-stop Biologics and Conjugates CDMO Platform successfully completed the full-cycle delivery of process development and GMP IND clinical sample manufacturing for a dual-payload ADC.